These press releases are intended for business journalists and analysts/investors
Professor Georgina Long and Professor Richard Scolyer win GSK Award for Research Excellence 2018
Immuno-oncology is the “penicillin moment” that will turn all cancers into a treatable condition, says winner.
Approval marks a major step in global eradication efforts and will support registrations in malaria-endemic countries
Read more - GSK Australia commits to new Reconciliation Action Plan Read more
Read more - Doctors encouraging middle-aged Aussie blokes to consider their prostate Read more
Trelegy Ellipta (fluticasone furoate, umeclidinium and vilanterol) - first, once-daily triple therapy for COPD reimbursed by the PBS in Australia
Read more - New treatment reimbursed for major breathing disorder Read more
Read more - GSK statement on influenza vaccine supply for the 2018 season Read more
- 38th year of $80,000 research grant
Read more - Nominations open for prestigious GSK Award for Research Excellence Read more
Read more - Simon Dingemans, Chief Financial Officer, to retire from GSK Read more
Read more - GSK Australia reports 2017 results to ASIC Read more